相关实验视频

Updated: Jun 23, 2026

Murine Model of Femoral Artery Wire Injury with Implantation of a Perivascular Drug Delivery Patch

Murine Model of Femoral Artery Wire Injury with Implantation of a Perivascular Drug Delivery Patch

Published on: February 10, 2015

生物工程治疗外周血管新极性增生症的策略:创新和挑战

Nikita Wilson John¹, Caitlyn Dang², Nidhi Reddy²

¹Department of Biomedical Engineering, Northwestern University, 2145 Sheridan Road, Evanston, Chicago, IL, 60208, USA.

Advanced healthcare materials

|January 31, 2025

概括

生物工程策略为治疗新极端增生症 (neointimal hyperplasia) 提供了新的希望,这种情况导致干预后血管收窄. 这些先进的方法旨在改善血管手术患者的愈合和长期结果.

科学领域:

生物医学工程生物医学工程
再生医学是一种再生医学.
血管生物学血管生物学

背景情况:

新极度增生症是一种病理性血管反应,干预后导致静脉缩.
它显著影响了外周血管手术的长期成功.
目前的治疗方法面临局限性,需要新的治疗策略.

研究的目的:

提供对新兴生物工程策略的综合审查,以治疗外围血管中新极端增生症.
突出新型疗法,基于细胞的技术和先进的输送方式.
探索代表性不足的治疗目标,以改善干预结果.

主要方法:

对生物工程方法对新极致增生症的当前文献的综述.
分析包括新疗法,基于细胞的技术和先进的传递系统在内的战略.
识别超越传统治疗范式的新兴目标.

主要成果:

新兴的生物工程战略侧重于促进重新内皮质化和调节血管光滑肌细胞 (VSMC) 现型.
方法旨在减少炎症,清除活性氧物种 (ROS),并改善移植器和移植器的生物机械兼容性.
先进的输送方式可以在血管损伤部位进行有针对性的局部治疗.

结论:

生物工程提出了一个有希望的路线图,用于更有效的新极端增生症治疗.
新的方法有可能改善血管干预后患者的治疗结果.
对代表性不足的目标进行进一步的研究可以打开新的治疗机会.

关键词:

动脉静脉复缩症动脉静脉复缩症生物工程方法的方法.基于细胞的疗法.局部化药物输送提供.新极端的增生过度增生.血管操纵是一种血管操纵.

更多相关视频

A Rabbit Venous Interposition Model Mimicking Revascularization Surgery using Vein Grafts to Assess Intimal Hyperplasia under Arterial Blood Pressure

A Rabbit Venous Interposition Model Mimicking Revascularization Surgery using Vein Grafts to Assess Intimal Hyperplasia under Arterial Blood Pressure

Published on: May 15, 2020

Development of a Murine Model for Femoral Artery Anastomotic Stenosis

Development of a Murine Model for Femoral Artery Anastomotic Stenosis

Published on: April 18, 2025

相关概念视频

Mechanism of Angiogenesis

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...